Merck just received breakthrough status for their lung cancer treatment keytruda. With mercks unhindered funding, Can this harm ariads success with 113 moving forward?
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.